Search

You searched for "emergencies"

1490 results found

Through the eyes of artists, part one: The effects of cataracts on Monet and Cassatt

3 February 2026 | | EYE - Cataract
Ophthalmology and art are undoubtedly connected – for many artists they are inseparable, as their vision is fundamental to their work – it determines how they perceive colour and light in order to transform it into art. However, visual impairment...

Could the sclera be key to glaucoma?

1 December 2017 | | EYE - Glaucoma
The glaucomas are a group of conditions characterised by optic neuropathy and associated visual field defects. Of these, chronic open-angle glaucoma (COAG) – diagnosed on the basis of progressive structural changes to the optic nerve head (ONH) and nerve fibre...

Retinopathy of prematurity treatment in the South West of England: long-term outcomes 1997-2008

1 December 2014 | | EYE - Vitreo-Retinal
Retinopathy of prematurity (ROP) is a condition that affects the developing retinal vascular system of pre-term babies. If left untreated, ROP can lead to severe visual impairment. The severe visual impairment caused by untreated ROP can be prevented by screening...

Newer generation IOL platforms designed for high-quality visual performance after cataract surgery

1 April 2019 | | EYE - Cataract, EYE - Refractive, EYE - General
Expanding intraocular lens (IOL) capabilities provide broadening options, ranging from next-generation monofocal IOLs for basic cataract surgery, to specialised premium IOLs for lens-based presbyopia correction and astigmatism correction at the time of cataract surgery. Rod McNeil considers several newer alternative...

Renewed momentum in ocular gene and cell therapy, broadening application to chronic disease

5 February 2020 | | EYE - Vitreo-Retinal, EYE - General
Gene and cell therapies offer the prospect of ground-breaking new avenues for the treatment of diseases, reflected in a renewed explosion of interest and investment in retinal gene therapy. Rod McNeil reports recent clinical trial readouts across a diverse range...

A trip up north: Eye News Symposium 2020

24 February 2020
New accents, friendly smiles and haggis served with my traditional morning breakfast, I knew at this point that I was a long way from the south of England, where this story begins.

Archery enthusiast’s sight is back on target following ‘life-changing’ eye surgery for cataracts

16 December 2022
Retired bus driver and keen archer Roger Kent is feeling grateful for his improved quality of life after undergoing successful cataract surgery at Freedom Vision in Bolton.

From dry eyes to glaucoma: How the menopause impacts your eyes and what to do about it, according to an optician

25 October 2024 | menopause, dry eye, eye drops, Nimmi Mistry, WMD2024, cornea, glaucoma, cataracts, oestrogen, Vision Direct, opticians, optometry
Menopause, much like entering puberty, comes with hormonal disruptions that change a woman's body and behaviour. Some of the first visible side effects are hot flushes, weight gain, and acne, accompanied by behavioural symptoms like mood swings, insomnia, and brain...

New research shows the unhealthy state of access to medicine and medical devices for blind patients

30 April 2025 | RNIB, The Safety Gap, risk assessment, diabetes, patient experience, public awareness
Blind and partially sighted people could become ill from medicines and medical devices, because they are not being listened to when it comes to designing, prescribing and administering treatments. The Safety Gap’ report commissioned by the Patient Safety Commissioner, Prof...

Treatment for cause of sudden sight loss now available through the NHS in England

24 September 2025 | LHON, NICE, vision Loss, mitochondrial disease, NHS England
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...

NICE approves treatment for cause of sudden sight loss

15 October 2025 | genetics, neuro-ophthalmology, drugs, new treatments, mitochondrial
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...

Specialty doctor interviews

1 February 2019 | | EYE - General
I started my training as an ophthalmologist in the Wild West of Carmarthenshire where I did my first laser procedure, first phacoemulsification and first slit-lamp examination. All of these firsts were done under the tutelage of very skilled staff grade...